1,2-dimethylhydrazine increases expression ISO RGD:1323346 6480464 1, 2-Dimethylhydrazine results in increased expression of ARID5B mRNA CTD PMID:22206623 17alpha-ethynylestradiol multiple interactions ISO RGD:1323346 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ARID5B mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:1323345 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of ARID5B mRNA, EGF protein inhibits the reaction [Estradiol results in decreased expression of ARID5B mRNA] CTD PMID:24758408 , PMID:30165855 17beta-estradiol affects expression ISO RGD:1323345 6480464 Estradiol affects the expression of ARID5B mRNA CTD PMID:22574217 17beta-estradiol decreases expression ISO RGD:1323345 6480464 Estradiol results in decreased expression of ARID5B mRNA CTD PMID:24758408 , PMID:31614463 2,2',5,5'-tetrachlorobiphenyl decreases expression EXP 6480464 2 more ... CTD PMID:23829299 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1323346 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ARID5B mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1323346 6480464 Tetrachlorodibenzodioxin affects the expression of ARID5B mRNA CTD PMID:21570461 2-hydroxypropanoic acid decreases expression ISO RGD:1323345 6480464 Lactic Acid results in decreased expression of ARID5B mRNA CTD PMID:30851411 2-methylcholine affects expression ISO RGD:1323345 6480464 beta-methylcholine affects the expression of ARID5B mRNA CTD PMID:21179406 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:1323346 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of ARID5B mRNA CTD PMID:26251327 4,4'-sulfonyldiphenol increases expression ISO RGD:1323346 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of ARID5B mRNA CTD PMID:33297965 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1323345 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of ARID5B gene CTD PMID:31601247 5-fluorouracil affects response to substance ISO RGD:1323345 6480464 ARID5B protein affects the susceptibility to Fluorouracil CTD PMID:16217747 7-Hydroxymethotrexate affects abundance ISO RGD:1323345 6480464 ARID5B gene SNP affects the abundance of 7-hydroxymethotrexate CTD PMID:24712521 8-Br-cAMP decreases expression ISO RGD:1323345 6480464 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ARID5B mRNA CTD PMID:22079614 all-trans-retinoic acid increases expression ISO RGD:1323345 6480464 Tretinoin results in increased expression of ARID5B mRNA CTD PMID:21934132 arsane multiple interactions ISO RGD:1323345 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ARID5B mRNA CTD PMID:32525701 arsane increases methylation ISO RGD:1323345 6480464 Arsenic results in increased methylation of ARID5B gene CTD PMID:30746931 arsane affects expression ISO RGD:1323345 6480464 Arsenic affects the expression of ARID5B mRNA CTD PMID:30746931 arsenic atom multiple interactions ISO RGD:1323345 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ARID5B mRNA CTD PMID:32525701 arsenic atom affects expression ISO RGD:1323345 6480464 Arsenic affects the expression of ARID5B mRNA CTD PMID:30746931 arsenic atom increases methylation ISO RGD:1323345 6480464 Arsenic results in increased methylation of ARID5B gene CTD PMID:30746931 arsenite(3-) multiple interactions ISO RGD:1323345 6480464 arsenite inhibits the reaction [G3BP1 protein binds to ARID5B mRNA] CTD PMID:32406909 arsenous acid decreases expression ISO RGD:1323345 6480464 Arsenic Trioxide results in decreased expression of ARID5B mRNA CTD PMID:27829220 atrazine increases expression ISO RGD:1323345 6480464 Atrazine results in increased expression of ARID5B mRNA CTD PMID:22378314 benzo[a]pyrene decreases expression ISO RGD:1323346 6480464 Benzo(a)pyrene results in decreased expression of ARID5B mRNA CTD PMID:19770486 benzo[a]pyrene increases expression ISO RGD:1323345 6480464 Benzo(a)pyrene results in increased expression of ARID5B mRNA CTD PMID:32234424 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1323345 6480464 7 more ... CTD PMID:26238291 beta-naphthoflavone decreases expression ISO RGD:1323345 6480464 beta-Naphthoflavone results in decreased expression of ARID5B mRNA CTD PMID:32858204 biochanin A increases expression ISO RGD:1323345 6480464 biochanin A results in increased expression of ARID5B mRNA CTD PMID:12111696 bisphenol A increases expression ISO RGD:1323346 6480464 bisphenol A results in increased expression of ARID5B mRNA CTD PMID:26063408 , PMID:32156529 bisphenol A multiple interactions ISO RGD:1323345 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of ARID5B gene CTD PMID:31601247 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ARID5B mRNA CTD PMID:34947998 bisphenol A increases expression ISO RGD:1323345 6480464 bisphenol A results in increased expression of ARID5B mRNA CTD PMID:29275510 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ARID5B mRNA CTD PMID:25181051 butan-1-ol multiple interactions ISO RGD:1323345 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ARID5B mRNA CTD PMID:29432896 butyric acid increases expression ISO RGD:1323345 6480464 Butyric Acid results in increased expression of ARID5B mRNA CTD PMID:34581912 cadmium atom multiple interactions ISO RGD:1323345 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ARID5B mRNA CTD PMID:35301059 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of ARID5B mRNA CTD PMID:33453195 cadmium dichloride multiple interactions ISO RGD:1323345 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ARID5B mRNA CTD PMID:35301059 celastrol decreases expression ISO RGD:1323345 6480464 celastrol results in decreased expression of ARID5B mRNA CTD PMID:17010675 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of ARID5B mRNA CTD PMID:23125180 cisplatin affects response to substance ISO RGD:1323345 6480464 ARID5B protein affects the susceptibility to Cisplatin CTD PMID:16217747 cisplatin decreases expression ISO RGD:1323345 6480464 Cisplatin results in decreased expression of ARID5B mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:1323345 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of ARID5B mRNA CTD PMID:27392435 copper(II) sulfate increases expression ISO RGD:1323345 6480464 Copper Sulfate results in increased expression of ARID5B mRNA CTD PMID:19549813 crocidolite asbestos increases expression ISO RGD:1323345 6480464 Asbestos, Crocidolite results in increased expression of ARID5B mRNA CTD PMID:18687144 crocidolite asbestos decreases expression ISO RGD:1323346 6480464 Asbestos, Crocidolite results in decreased expression of ARID5B mRNA CTD PMID:29279043 dexamethasone increases expression ISO RGD:1323346 6480464 Dexamethasone results in increased expression of ARID5B mRNA CTD PMID:22733784 diarsenic trioxide decreases expression ISO RGD:1323345 6480464 Arsenic Trioxide results in decreased expression of ARID5B mRNA CTD PMID:27829220 dibutyl phthalate increases expression ISO RGD:1323346 6480464 Dibutyl Phthalate results in increased expression of ARID5B mRNA CTD PMID:17361019 , PMID:21266533 diclofenac decreases expression ISO RGD:1323346 6480464 Diclofenac results in decreased expression of ARID5B mRNA CTD PMID:26934552 dorsomorphin multiple interactions ISO RGD:1323345 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1323345 6480464 Doxorubicin results in decreased expression of ARID5B mRNA CTD PMID:29803840 epoxiconazole decreases expression ISO RGD:1323346 6480464 epoxiconazole results in decreased expression of ARID5B mRNA CTD PMID:35436446 ethanol affects expression ISO RGD:1323346 6480464 Ethanol affects the expression of ARID5B mRNA CTD PMID:30319688 ethyl methanesulfonate increases expression ISO RGD:1323345 6480464 Ethyl Methanesulfonate results in increased expression of ARID5B mRNA CTD PMID:23649840 folic acid decreases expression ISO RGD:1323345 6480464 Folic Acid results in decreased expression of ARID5B mRNA CTD PMID:21867686 formaldehyde increases expression ISO RGD:1323345 6480464 Formaldehyde results in increased expression of ARID5B mRNA CTD PMID:23649840 fulvestrant multiple interactions ISO RGD:1323345 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of ARID5B gene CTD PMID:31601247 gedunin decreases expression ISO RGD:1323345 6480464 gedunin results in decreased expression of ARID5B mRNA CTD PMID:17010675 hydrogen cyanide increases expression ISO RGD:1323346 6480464 Hydrogen Cyanide results in increased expression of ARID5B mRNA CTD PMID:33914522 indometacin decreases expression ISO RGD:1323345 6480464 Indomethacin results in decreased expression of ARID5B mRNA CTD PMID:16984733 isobutanol multiple interactions ISO RGD:1323345 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ARID5B mRNA CTD PMID:29432896 isoprenaline increases expression ISO RGD:1323346 6480464 Isoproterenol results in increased expression of ARID5B mRNA CTD PMID:20003209 leflunomide increases expression ISO RGD:1323345 6480464 leflunomide results in increased expression of ARID5B mRNA CTD PMID:28988120 mercury dibromide increases expression ISO RGD:1323345 6480464 mercuric bromide results in increased expression of ARID5B mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1323345 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARID5B mRNA CTD PMID:27188386 methotrexate affects abundance ISO RGD:1323345 6480464 ARID5B gene SNP affects the abundance of Methotrexate CTD PMID:24712521 methyl methanesulfonate increases expression ISO RGD:1323345 6480464 Methyl Methanesulfonate results in increased expression of ARID5B mRNA CTD PMID:23649840 methylisothiazolinone increases expression ISO RGD:1323345 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of ARID5B mRNA CTD PMID:31629900 panobinostat multiple interactions ISO RGD:1323345 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARID5B mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:1323345 6480464 panobinostat results in increased expression of ARID5B mRNA CTD PMID:26272509 pentanal decreases expression ISO RGD:1323345 6480464 pentanal results in decreased expression of ARID5B mRNA CTD PMID:26079696 phenobarbital decreases expression ISO RGD:1323346 6480464 Phenobarbital results in decreased expression of ARID5B mRNA CTD PMID:19270015 phenobarbital affects expression ISO RGD:1323346 6480464 Phenobarbital affects the expression of ARID5B mRNA CTD PMID:23091169 phenylmercury acetate increases expression ISO RGD:1323345 6480464 Phenylmercuric Acetate results in increased expression of ARID5B mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1323345 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARID5B mRNA CTD PMID:27188386 pirinixic acid multiple interactions ISO RGD:1323345 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ARID5B mRNA CTD PMID:19710929 pirinixic acid decreases expression ISO RGD:1323346 6480464 pirinixic acid results in decreased expression of ARID5B mRNA CTD PMID:20813756 , PMID:23811191 potassium chloride multiple interactions ISO RGD:1323345 6480464 [Dronabinol results in decreased susceptibility to Potassium Chloride] which results in increased expression of ARID5B mRNA CTD PMID:29691375 potassium cyanide increases expression ISO RGD:1323346 6480464 Potassium Cyanide results in increased expression of ARID5B mRNA CTD PMID:33914522 potassium dichromate decreases expression ISO RGD:1323346 6480464 Potassium Dichromate results in decreased expression of ARID5B mRNA CTD PMID:23608068 rac-lactic acid decreases expression ISO RGD:1323345 6480464 Lactic Acid results in decreased expression of ARID5B mRNA CTD PMID:30851411 raloxifene affects expression ISO RGD:1323345 6480464 Raloxifene Hydrochloride affects the expression of ARID5B mRNA CTD PMID:14699072 rotenone affects expression EXP 6480464 Rotenone affects the expression of ARID5B mRNA CTD PMID:28374803 S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO RGD:1323345 6480464 S-(1, 2-dichlorovinyl)cysteine results in decreased expression of ARID5B mRNA CTD PMID:33725128 SB 431542 multiple interactions ISO RGD:1323345 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:1323345 6480464 Silicon Dioxide analog results in decreased expression of ARID5B mRNA CTD PMID:25895662 silver atom increases expression ISO RGD:1323345 6480464 Silver results in increased expression of ARID5B mRNA CTD PMID:26014281 silver(0) increases expression ISO RGD:1323345 6480464 Silver results in increased expression of ARID5B mRNA CTD PMID:26014281 sodium arsenate decreases expression ISO RGD:1323346 6480464 sodium arsenate results in decreased expression of ARID5B mRNA CTD PMID:21795629 sodium arsenate multiple interactions ISO RGD:1323345 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ARID5B mRNA CTD PMID:32525701 sodium arsenite increases expression ISO RGD:1323346 6480464 sodium arsenite results in increased expression of ARID5B mRNA CTD PMID:16014739 sodium arsenite increases expression ISO RGD:1323345 6480464 sodium arsenite results in increased expression of ARID5B mRNA CTD PMID:29301061 sodium arsenite multiple interactions ISO RGD:1323345 6480464 [sodium arsenite co-treated with sodium arsenite deficiency] results in decreased methylation of ARID5B promoter CTD PMID:28336213 Soman increases expression EXP 6480464 Soman results in increased expression of ARID5B mRNA CTD PMID:19281266 sulforaphane decreases expression ISO RGD:1323345 6480464 sulforaphane results in decreased expression of ARID5B mRNA CTD PMID:31838189 tamoxifen affects expression ISO RGD:1323346 6480464 Tamoxifen affects the expression of ARID5B mRNA CTD PMID:20937368 tamoxifen affects expression ISO RGD:1323345 6480464 Tamoxifen affects the expression of ARID5B mRNA CTD PMID:14699072 tetrachloromethane increases expression ISO RGD:1323346 6480464 Carbon Tetrachloride results in increased expression of ARID5B mRNA CTD PMID:31919559 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ARID5B mRNA CTD PMID:34492290 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of ARID5B gene CTD PMID:27618143 trichostatin A increases expression ISO RGD:1323345 6480464 trichostatin A results in increased expression of ARID5B mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1323345 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARID5B mRNA CTD PMID:27188386 triclosan increases expression ISO RGD:1323345 6480464 Triclosan results in increased expression of ARID5B mRNA CTD PMID:30510588 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of ARID5B mRNA CTD PMID:30589522 trovafloxacin multiple interactions ISO RGD:1323346 6480464 [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of ARID5B mRNA CTD PMID:18930950 tunicamycin decreases expression ISO RGD:1323345 6480464 Tunicamycin results in decreased expression of ARID5B mRNA CTD PMID:29453283 valproic acid affects expression ISO RGD:1323346 6480464 Valproic Acid affects the expression of ARID5B mRNA CTD PMID:17963808 valproic acid affects expression ISO RGD:1323345 6480464 Valproic Acid affects the expression of ARID5B mRNA CTD PMID:25979313 valproic acid multiple interactions ISO RGD:1323345 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARID5B mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1323345 6480464 Valproic Acid results in increased expression of ARID5B mRNA CTD PMID:23179753 more ... vinclozolin increases methylation EXP 6480464 vinclozolin results in increased methylation of ARID5B gene CTD PMID:31682807 vorinostat increases expression ISO RGD:1323345 6480464 vorinostat results in increased expression of ARID5B mRNA CTD PMID:26272509 , PMID:27188386
